Molecular Mechanisms of the Antiatherogenic Action of Adiponectin

Author(s): Kunihisa Kobayashi, Toyoshi Inoguchi

Journal Name: Vascular Disease Prevention (Discontinued)

Volume 4 , Issue 1 , 2007

Abstract:

Recently, many investigators have reported that adipocytes secrete a variety of bioactive substances, termed adipokines (adipocytokines), including tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), leptin, resistin, adiponectin and so on. Adiponectin is most abundant in the plasma and produced exclusively by adipocytes. This adipokine has been reported to be an exciting player in the field of energy homeostasis regulation. Furthermore, adiponectin has been shown to have antiatherogenic properties in epidemiological, in vitro and in vivo studies. This review summarizes the currently available information regarding this important biomolecule and discusses its feasibility for the treatment of atherosclerotic diseases.

Keywords: Adipokine, adiponectin, diabetes mellitus, atherosclerosis, insulin resistance, biglycan, subendothelial retention, low-density lipoprotein

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 4
ISSUE: 1
Year: 2007
Page: [7 - 9]
Pages: 3
DOI: 10.2174/1567270010704010007

Article Metrics

PDF: 3